| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00125-013-3136-1 |
| P698 | PubMed publication ID | 24362725 |
| P2093 | author name string | Hua Liang | |
| Qian Gao | |||
| Wenjun Wu | |||
| Junfeng Shi | |||
| Yan Bi | |||
| Jianping Weng | |||
| Dalong Zhu | |||
| Shanmei Shen | |||
| Sunyinyan Tang | |||
| Shu Cao | |||
| Yingying Chen | |||
| Mengyin Cai | |||
| Wenwen Yin | |||
| P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
| siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle | Q24295160 | ||
| Inflammation, stress, and diabetes | Q24523336 | ||
| Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice | Q28144106 | ||
| Defects of the insulin receptor substrate (IRS) system in human metabolic disorders | Q28200997 | ||
| SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver | Q28240899 | ||
| SREBP-1c transcription factor and lipid homeostasis: clinical perspective | Q28291930 | ||
| Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats | Q28580360 | ||
| AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice | Q28591122 | ||
| Reactive oxygen species have a causal role in multiple forms of insulin resistance | Q29619831 | ||
| Mechanisms for insulin resistance: common threads and missing links | Q29620447 | ||
| Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism | Q33830715 | ||
| Mechanisms of insulin resistance in humans and possible links with inflammation | Q36095510 | ||
| Expanding roles for SREBP in metabolism | Q36303731 | ||
| Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes | Q36321560 | ||
| Etiology of insulin resistance | Q36431215 | ||
| Lipotoxicity, overnutrition and energy metabolism in aging | Q36456209 | ||
| SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling | Q36728656 | ||
| SREBPs: the crossroads of physiological and pathological lipid homeostasis | Q37091373 | ||
| Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs | Q37155389 | ||
| Free fatty acids and skeletal muscle insulin resistance | Q37156298 | ||
| Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse | Q37376749 | ||
| Skeletal muscle insulin resistance is the primary defect in type 2 diabetes | Q37624257 | ||
| Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver | Q38297185 | ||
| Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. | Q39185452 | ||
| Palmitate-induced skeletal muscle insulin resistance does not require NF-κB activation | Q39658915 | ||
| Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes. | Q40447329 | ||
| Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 | ||
| Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats | Q43274457 | ||
| Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes | Q43833528 | ||
| Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression | Q44007196 | ||
| Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway | Q44811195 | ||
| Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element-binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat-diet and streptozotoci | Q46046290 | ||
| SREBPs suppress IRS-2-mediated insulin signalling in the liver | Q47868873 | ||
| Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor. | Q51455793 | ||
| Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells. | Q53595198 | ||
| Identification of a functional DNA binding site for the SREBP-1c transcription factor in the first intron of the human caspase-2 gene | Q57220271 | ||
| P433 | issue | 3 | |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 592-602 | |
| P577 | publication date | 2013-12-21 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription | |
| P478 | volume | 57 |
| Q41815877 | Flavonoid-Rich Extract of Paulownia fortunei Flowers Attenuates Diet-Induced Hyperlipidemia, Hepatic Steatosis and Insulin Resistance in Obesity Mice by AMPK Pathway |
| Q95270733 | Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease |
| Q89362520 | Petroleum ether sub-fraction of rosemary extract improves hyperlipidemia and insulin resistance by inhibiting SREBPs |
| Q35325687 | Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin resistance |
| Q92480818 | Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice |
| Q38925816 | Suppression of Rho-kinase 1 is responsible for insulin regulation of the AMPK/SREBP-1c pathway in skeletal muscle cells exposed to palmitate |
| Q53817935 | The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance. |
| Q50889958 | Zinc mediates the SREBP-SCD axis to regulate lipid metabolism in Caenorhabditis elegans. |
| Q47352692 | mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci. |
Search more.